Xiuqing Li, Ph.D. - Publications

Affiliations: 
2011 Pathobiology University of Southern California, Los Angeles, CA, United States 
Area:
Physiology Biology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Li X, Zhang J, Wu Y, Ma C, Wei D, Pan L, Cai L. Erratum: IGFBP7 remodels the tumor microenvironment of esophageal squamous cell carcinoma by activating the TGFβ1/SMAD signaling pathway. Oncology Letters. 25: 35. PMID 36589671 DOI: 10.3892/ol.2022.13621  0.348
2022 Li X, Zhang J, Wu Y, Ma C, Wei D, Pan L, Cai L. IGFBP7 remodels the tumor microenvironment of esophageal squamous cell carcinoma by activating the TGFβ1/SMAD signaling pathway. Oncology Letters. 24: 251. PMID 35761941 DOI: 10.3892/ol.2022.13371  0.358
2016 Liang M, Adisetiyo H, Li X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. Plos One. 11: e0152243. PMID 26998759 DOI: 10.1371/journal.pone.0152243  0.448
2015 Yu H, Liu R, Ma B, Li X, Yen HY, Zhou Y, Krasnoperov V, Xia Z, Zhang X, Bove AM, Buscarini M, Parekh D, Gill IS, Liao Q, Tretiakova M, et al. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma. British Journal of Cancer. PMID 26180925 DOI: 10.1038/Bjc.2015.237  0.557
2014 Li X, Choi WW, Yan R, Yu H, Krasnoperov V, Kumar SR, Schuckman A, Klumpp DJ, Pan CX, Quinn D, Gill IS, Gill PS, Liu R. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. Plos One. 9: e105326. PMID 25148033 DOI: 10.1371/Journal.Pone.0105326  0.668
2014 Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft. Molecular Pharmaceutics. 11: 3974-9. PMID 24978094 DOI: 10.1021/Mp500307T  0.549
2013 Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti PS, Li Z, Lee AS, et al. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6802-11. PMID 24048331 DOI: 10.1158/1078-0432.Ccr-13-1106  0.65
2013 Hasina R, Mollberg N, Kawada I, Mutreja K, Kanade G, Yala S, Surati M, Liu R, Li X, Zhou Y, Ferguson BD, Nallasura V, Cohen KS, Hyjek E, Mueller J, et al. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Research. 73: 184-94. PMID 23100466 DOI: 10.1158/0008-5472.Can-12-0915  0.653
2013 Liang M, Adisetiyo HA, Li X, Liu R, Gill PS, Roy-Burman P. Abstract 4087: Androgen receptor splice variants in mouse prostate cancer cell lines: altered distribution in lines derived from castration-resistant tumors relative to those primary tumors. Cancer Research. 73: 4087-4087. DOI: 10.1158/1538-7445.Am2013-4087  0.6
2012 Hasina R, Mutreja K, Kawada I, Kanteti R, Arif Q, Liu R, Li X, Zhou Y, Hyjek E, Lingen MW, Mueller J, Waxman I, Villaflor V, Ferguson M, Vokes EE, et al. Abstract 1861: EPHB4 as a potential therapeutic target for esophageal cancer Cancer Research. 72: 1861-1861. DOI: 10.1158/1538-7445.Am2012-1861  0.58
2010 Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. Bmc Cancer. 10: 641. PMID 21092311 DOI: 10.1186/1471-2407-10-641  0.631
2010 Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood. 116: 297-305. PMID 20442363 DOI: 10.1182/Blood-2009-12-257154  0.701
2010 Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS. Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. The American Journal of Pathology. 176: 2029-38. PMID 20133814 DOI: 10.2353/Ajpath.2010.090755  0.661
2010 Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 115: 887-95. PMID 19965636 DOI: 10.1182/Blood-2009-08-236745  0.657
Show low-probability matches.